Lactulose-mediated Bifidobacteria expansion promotes a beneficial fecal metabolite profile that is associated with exclusion of antibiotic-resistant pathogens and improved outcomes in advanced liver disease

The link between gut microbiome of chronic liver disease (CLD) and clinical outcomes of the patients is lacking in the field, and this study takes a chance in investigating the relationship metagenomically and metabolomical, along with animal experiments.